Home/Filings/4/0001144204-06-024799
4//SEC Filing

SCHEIN JOSHUA D 4

Accession 0001144204-06-024799

CIK 0001144062other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:53 PM ET

Size

7.4 KB

Accession

0001144204-06-024799

Insider Transaction Report

Form 4
Period: 2006-06-13
SCHEIN JOSHUA D
DirectorCEO10% Owner
Transactions
  • Purchase

    Common Stock

    2006-06-13$0.59/sh+1,500$885996,005 total
  • Purchase

    Common Stock

    2006-06-13$0.56/sh+1,000$560994,505 total
Holdings
  • Common Stock

    (indirect: see footnote)
    27,473,417
Footnotes (1)
  • [F1]Consists of shares of common stock owned by Prism Ventures, a limited liability company in which Mr. Schein owns a 50% interest, and the following entities, all of which are owned by Prism Ventures, LLC: Newton Partners, LLC, Windsor Ventures, LLC, Sapphire Ventures, LLC, Tudor Technology Ventures, LLC and Entry Point Capital LLC.

Documents

1 file

Issuer

Lev Pharmaceuticals Inc

CIK 0001144062

Entity typeother

Related Parties

1
  • filerCIK 0001313875

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:53 PM ET
Size
7.4 KB